Retailers file amended US antitrust claims against Teva over Copaxone
MLex Summary: Walgreen, Kroger Co., Albertsons Cos. and H-E-B filed an amended US complaint accusing Teva Pharmaceuticals of illegally delaying a generic competitor for multiple sclerosis treatment drug Copaxone. According to the...To view the full article, register now.
Already a subscriber? Click here to view full article